FDA Inspection
Ascend Laboratories, LLCAscend Laboratories, LLC – FDA Inspection, Jun 24, 2021
Record Details
This FDA Inspection record concerns Ascend Laboratories, LLC, with an inspection on June 24, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Ascend Laboratories, LLC
- Inspection Date
- June 24, 2021
- Product Type
- Drugs
View Company Profile
ID · e55e745a-baef-46b3-95de-8b60776f8c34
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1144680
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ascend Laboratories, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 10, 2021 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 6, 2017 | NAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| December 11, 2013 | OAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| February 10, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Ascend Laboratories, LLC
- FDA Inspection 1156395 - 2021-11-10
- FDA Inspection 1023638 - 2017-07-06
- FDA Inspection 856772 - 2013-12-11
- FDA Inspection 709952 - 2011-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.